期刊文献+

中药导致急性肝损伤临床研究 被引量:8

A clinical study on cases with traditional Chinese medicine induced liver injury
下载PDF
导出
摘要 目的探讨中药所致急性肝损伤的临床特点。方法制定标准化的药物性肝损伤病案调查表,采用病例登记和随访,以及RUCAM评分系统,从急性药物性肝损伤患者中筛选出中药导致急性肝损伤相关病例,分析中药所致肝损伤的类型、临床表现、肝损伤严重程度等。结果在132例中药导致急性肝损伤相关病例中,男性59例,女性73例,平均年龄(51.6±17.5)岁。肝细胞型肝损伤107例,胆汁淤积型肝损伤20例,混合型肝损伤5例。轻度肝损伤10例(7.6%),中度肝损伤104例(78.8%),重度肝损伤16例(12.1%),致命性肝损伤2例(1.5%)。导致急性肝损伤的中药种类繁多,大多数药物系含有多种中药成分(26.5%),或具体药物成分不详的中药(56.8%)。结论中药导致肝损伤以肝细胞型为主,少数病例为重症或致死性,临床医生需要重视中药肝毒性。 Objective To investigate the clinical characteristics of cases with acute traditional Chinese medicine (TCM)induced liver injury.Methods We drew up the standardized case report forms of drug-induced liver injury,then filtered the clinical records of cases with acute TCM-induced liver injury from drug-induced liver injury cases by using standardized registration,follow-up and RUCAM,and analyzed the injury types,clinical presentation,severity grading of drug-induced liver injury.Results Among the evaluated 132 cases, there were 59 males and 73 females.The average age was (51.6 ±17.5)years .107 patients were classified as hepatocellular injury, 20 patients cholestatic injury,and 5 patients mixed injury.There were 10 patients whose severity grading of liver injury was mild (grade 1),104 patients moderate (grade 2),16 patients severe (grade 3),and 2 patients fatal (grade 4).TCMcategories causing acute liver injury varied.More than half of the medicine were mixture of much unknown TCM.Conclusions These results suggested that the hepa-tocellular injury was the predominant clinical pattern in acute TCM-induced liver injury.A small number of patients showed severe to fa-tal liver injury.Therefore,doctors should attach importance to TCMhepatotoxicity.
出处 《安徽医药》 CAS 2015年第10期1997-2000,共4页 Anhui Medical and Pharmaceutical Journal
关键词 药物性肝损伤 肝毒性 中药 drug-induced liver injury hepatotoxicity traditional Chinese medicine
  • 相关文献

参考文献15

  • 1StickeF,ShouvalD.Hepatotoxicityofherbalanddietarysupple-ments:anupdate[J].ArchToxicol,2015,89(6):851-865.
  • 2TeschkeR,FrenzelC,GlassX,etal.Herbalhepatotoxicity:acriti-calreview[J].BrJClinPharmacol,2012,75(3):630-636.
  • 3AithalGP,WatkinsPB,AndradeRJ,etal.Casedefinitionandphenotypestandardizationindrug-inducedliverinjury[J].ClinPharmacolTher,2011,89(6):806-815.
  • 4LivertoxDatabase.ImportantElementstoincludeinReportingCa-sesofDrug-inducedLiverInjury[EB/OL].https://livertox.nid-dk.nih.gov/Home/ImportantElements.
  • 5AviganMI,BjornssonES,PasanenM,etal.LiverSafetyAssess-ment:RequiredDataElementsandBestPracticesforDataCollec-tionandStandardizationinClinicalTrials[J].DrugSaf,2014,37(Suppl1):S19-S31.
  • 6RockeyDC.MethodofDILINinEstablishingCausality.AASLD-FDA-NIH-PhRMA HepatotoxicitySteeringGroupMeeting[EB/OL].http://www.fda.gov/Drugs/ScienceResearch/ResearchAr-eas/ucm079443.htm.
  • 7任晓非,许建明.急性药物性肝损伤诊断方法及评价[J].安徽医药,2008,12(5):390-393. 被引量:13
  • 8ChalasaniNP,HayashiPH,BonkovskyHL,etal.ACGClinicalGuideline:thediagnosisandmanagementofidiosyncraticdrug-in-ducedliverinjury[J].AmJGastroenterol,2014,109(7):950-966.
  • 9江学富,汪凯,汪朝辉,温已鹏.198例药物性肝损伤临床分析[J].安徽医药,2014,18(8):1553-1556. 被引量:18
  • 10急性重症药物性肝损伤全国多中心调查分析[J].中华消化杂志,2013,33(2):80-83. 被引量:18

二级参考文献35

  • 1厉有名.药物性肝损害的临床类型及诊断策略[J].中华肝脏病杂志,2004,12(7):445-446. 被引量:252
  • 2张涛,贾继东.87例药物性肝损害病因和临床表现分析[J].中国临床医生杂志,2006,34(3):29-31. 被引量:9
  • 3Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 4许建明.全国多中心急性药物性肝损伤住院病例调研分析[J].中华消化杂志,2007,27(7):439-442. 被引量:88
  • 5Rockey DC. Method of DILIN in Establishing Causality[OL]. AASLD- FDA-NIH-PhRMA.
  • 6Nathwani RA, Kaplowitz N. Drug hepatotoxicity[J].Clin Liver Dis pdf,2006,10(2) :207 -7.
  • 7Aithal GP, Rawlins MD, Day GP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatoxic adverse drug reactions [ J ]. J Hepatol,2000,33 (6) :949 - 52.
  • 8Benichou C. Criteria of drug-induced liver disorders : report of an international consensus meeting[ J ]. J Hepatol, 1990,11 (2) :272 - 6.
  • 9Benichou C, Danan G,Flahault A. Causality assessment of adverse reactions to drug. Ⅱ. An original model for validation of drug causality assessment methods:case reports with positive rechallenge [ J]. J Clin Epidemiol, 1993,46( 11 ) :1331 -6.
  • 10Navarro VJ, Senior JR. Drug-related hepatotoxicity [ J ]. N Engl J Med ,2006,35 (7) :731 - 9.

共引文献46

同被引文献138

引证文献8

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部